When Will Vyvanse Shortage End? 2026 Update

If you or someone in your family takes Vyvanse® for attention deficit hyperactivity disorder (ADHD) and moderate-to-severe binge eating disorder, you may be wondering “when will Vyvanse shortage end” and whether your next refill will be available. Unfortunately, there is no single nationwide end date. As of 2026, shortages and supply restrictions continue to affect certain generic lisdexamfetamine products, manufacturers, strengths, and pharmacies.

Brand-name Vyvanse may be easier to find in some areas, while generic lisdexamfetamine may be unavailable or offered only in limited quantities. Availability can change quickly. One pharmacy may have your prescribed strength while another nearby pharmacy does not.

This “Vyvanse shortage 2026” update explains which products are affected, why shortages continue, and what you can do when your pharmacy cannot fill your prescription.

“Is There a Vyvanse Shortage Right Now”?

“Is there a Vyvanse shortage” in 2026? Yes, at least for the generic version. According to the American Society of Health-System Pharmacists (ASHP), lisdexamfetamine dimesylate capsules remain listed as an active drug shortage, a status the U.S. Food and Drug Administration's (FDA) own shortage database also reflects. So if you've been asking whether there's a shortage of Vyvanse that's actually documented by federal or clinical sources (rather than just a rumor from your neighborhood pharmacy), the answer is yes.

That said, the picture isn't uniform. ASHP's shortage tracking shows that some generic manufacturers, including Apotex, Lannett, Rhodes, and Sun Pharma, report their lisdexamfetamine capsules as available, while others, such as Amneal, Hikma, and Mallinckrodt, report ongoing shortages tied to active-ingredient supply problems. Takeda, which makes brand-name Vyvanse, reports its product as available.

In other words, “is there still a Vyvanse shortage” worth worrying about depends heavily on which manufacturer's bottle your pharmacy normally stocks, your dose strength, and where you live.

If you're trying to keep up with “Vyvanse shortage news today”, the most reliable places to check are the FDA's Drug Shortages Database and ASHP's shortage detail page for lisdexamfetamine, both of which are updated as manufacturers submit new information. So “is Vyvanse still on shortage” as far as these official sources are concerned? Generic lisdexamfetamine, yes. Brand Vyvanse, generally no, though cost and insurance coverage can make brand a poor substitute for many families.

“Why Is There a Vyvanse Shortage” in the USA?

Why has the Vyvanse shortage lasted so long? The honest answer is that it's not one problem. It’s several overlapping ones built on top of each other starting in late 2022. Here's what's driving the “Vyvanse shortage USA” patients are still feeling in 2026.

DEA Manufacturing Quotas on Controlled Substances

Vyvanse is a Schedule II controlled substance under the Controlled Substances Act. This means the U.S. Drug Enforcement Administration (DEA) limits how much lisdexamfetamine manufacturers can produce each year through an aggregate production quota, or APQ.

These limits help reduce misuse and illegal distribution. However, they also prevent manufacturers from immediately increasing production when demand rises. Companies must first receive DEA approval.

The DEA has increased the production limit. For 2026, it set the lisdexamfetamine APQ at about 51.3 million grams, according to the Federal Register notice establishing the 2026 quotas. Even with a higher limit, manufacturers may need months to turn that additional allowance into medication that reaches pharmacies.

Surging ADHD Diagnoses and Demand

Demand for stimulant medications has continued to rise. A 2024 CDC report published in Morbidity and Mortality Weekly Report estimated that 15.5 million U.S. adults had a current ADHD diagnosis.

Among adults taking stimulant medication, 71.5% said they had trouble filling a prescription during the previous 12 months because the medication was unavailable. This suggests that demand for stimulants such as lisdexamfetamine has grown faster than manufacturers can increase supply, especially as more adults are diagnosed and begin treatment.

Active-Ingredient and Manufacturing Supply Issues

Some manufacturers have also reported production problems. According to ASHP’s shortage listing, some companies have reported problems obtaining or processing the active pharmaceutical ingredient used to make lisdexamfetamine capsules.

These company-specific problems add to the broader production limits. They also help explain why availability can vary between pharmacies and dosage strengths.

Some Generic Makers Not Producing at Full Capacity

DEA authorization and FDA approval do not guarantee that a manufacturer is producing lisdexamfetamine at full capacity. Some companies may distribute limited supplies unevenly, while others may not have increased production enough to meet demand.

This uneven production helps explain why national shortage databases may say supply is "improving" even though your pharmacy still cannot obtain your prescribed medication.

“When Will the Vyvanse Shortage End”?

“When will generic Vyvanse shortage end”? Unfortunately, neither the FDA nor ASHP publishes a firm resolution date, and drug shortages of this kind rarely end with a single announcement. Instead, they wind down gradually as more manufacturers report consistent supply, DEA quotas keep pace with demand, and API sourcing stabilizes.

There are signs of progress. The DEA's higher 2026 production quota for lisdexamfetamine is meant to give manufacturers more room to produce, and several generic companies are already reporting stock as available rather than backordered.

But when will the Vyvanse shortage end? Predictions should be taken with caution, because manufacturing lead times, ingredient sourcing, and distribution logistics mean that a quota increase approved at any point in time doesn't translate to full pharmacy shelves overnight.

Health-system pharmacists and industry trackers describe the trajectory as improving but not resolved, with some observers expecting more consistent nationwide availability to develop gradually through the year rather than all at once.

The most useful “Vyvanse shortage update” you can get isn't a prediction. It's checking your current status yourself. The FDA's Drug Shortages Database and ASHP's shortage detail page are both updated directly from manufacturer reports, so they reflect real-time changes far better than any single forecast can.

What to Do During the Vyvanse Shortage in 2026

Waiting on national supply chains to sort themselves out isn't much comfort when you're standing at the pharmacy counter with an empty bottle. Here's what actually helps in the meantime.

Call Ahead to Confirm Pharmacy Stock

Before you drive over or send a refill request, call your pharmacy directly and ask whether they currently have your dose and manufacturer in stock. Because shortages hit individual manufacturers unevenly, one pharmacy chain in your area may have supply while another down the street doesn't.

If your usual pharmacy is out, ask your pharmacist whether a nearby location within the same chain has stock they can transfer.

Ask About Brand vs Generic

If generic lisdexamfetamine is unavailable, ask your pharmacist and prescriber whether brand-name Vyvanse is an option. Since Takeda's brand product is generally more available, this can bridge a gap. However, it often costs more out of pocket and may require prior authorization if your insurance plan prefers the generic.

Talk to Your Prescriber About Alternatives

If you can't find lisdexamfetamine anywhere nearby, reach out to your prescriber before you go without treatment. They may be able to prescribe a different stimulant, a non-stimulant ADHD medication, or a different formulation that's easier to find in your area. This decision should always be made with a healthcare provider who knows your medical history, not on your own.

Refill Early When Allowed

Many state and pharmacy policies allow early refills when a documented shortage is affecting your medication. Ask your pharmacist about your options a week or two before you're due, rather than waiting until you're down to your last dose, so you have time to problem-solve if your usual supply isn't there.

Never Ration Doses or Take Someone Else's Medication

It can be tempting to stretch a partial supply or borrow a stimulant from a family member, but this isn't safe. Because Vyvanse and other stimulants are controlled substances with real physiological effects, changing your dose or source without medical guidance can affect your health and safety.

The CDC has specifically warned that disruptions in stimulant access can increase the risk of injury and, in some cases, push patients toward unregulated or counterfeit sources, which carry their own serious dangers. If you're struggling to access your medication safely, contact your prescriber rather than going around the system.

“When Will Vyvanse Shortage End”? Key Takeaways

The “Vyvanse shortage update” for 2026 comes down to this:

• Brand-name Vyvanse is generally available, but generic lisdexamfetamine remains on official drug shortage lists.
• Stock levels vary significantly depending on the specific manufacturer, dose strength, and local pharmacy location.
• The ongoing shortage stems from three main factors:
• Strict DEA annual production quotas on Schedule II controlled substances.
• A sharp increase in adult ADHD diagnoses and overall treatment demand.
• Persistent manufacturing delays and active-ingredient sourcing issues among generic producers.

While the DEA's higher 2026 production limit is good news, there is no set date for when the shortage will end. Expect pharmacy stock to improve slowly and unevenly across different regions.

In the meantime, you can protect your treatment plan by calling pharmacies ahead of time, asking about brand-name options, staying in close touch with your doctor, and requesting refills as early as legally allowed.

FAQs

 

“Is there still a Vyvanse shortage” in 2026?

Yes, generic lisdexamfetamine remains listed as an active shortage by ASHP and the FDA in 2026, though brand-name Vyvanse from Takeda is generally available. Availability of the generic varies significantly by manufacturer, dose strength, and pharmacy, so checking your specific dose is the best way to know where you stand.

Some generic manufacturers may report their lisdexamfetamine products as available, while others continue to report shortages tied to ingredient sourcing. That's why one pharmacy may have your prescription in stock while another nearby does not.

Brand Vyvanse vs generic lisdexamfetamine: What's actually in shortage?

The shortage primarily affects generic lisdexamfetamine, not brand-name Vyvanse. Several generic manufacturers report ongoing supply issues tied to active-ingredient sourcing, while Takeda's brand product is generally reported as available, though it typically costs more without insurance coverage.

This split matters for your wallet as much as your access. Brand Vyvanse can run several hundred dollars a month without discounts, while the generic, when available, is often far less expensive.

What can I take instead of Vyvanse during the shortage?

There's no single substitute for everyone, since ADHD treatment is individualized. Some patients may be switched to a different stimulant, a non-stimulant ADHD medication, or a different formulation. Still, this decision should always be made together with your prescriber based on your health history.

Never substitute another person's medication or an unregulated source for your prescribed treatment. If your pharmacy is out of stock, contact your prescriber promptly so you can discuss safe, medically appropriate alternatives rather than going without treatment or seeking medication outside the regulated healthcare system.

How can I find a pharmacy with Vyvanse in stock?

Start by calling your regular pharmacy directly and asking about your specific dose and manufacturer, since shortages affect companies unevenly. If they're out, ask whether another location in the same chain has stock they can transfer to you.

You can also compare estimated prices at pharmacies near you using ScriptSave® WellRx, which may help you find a nearby location worth calling. Your pharmacist can also tell you whether early refills are permitted in your state due to the ongoing shortage.

Why does my pharmacy keep running out of Vyvanse?

Your pharmacy's supply depends on which manufacturers it orders from, and several generic lisdexamfetamine makers have reported inconsistent production due to active-ingredient sourcing issues and DEA-regulated production quotas. When one manufacturer's supply runs low, pharmacies that rely on it can run out even if other brands are in stock elsewhere. This is also affected by demand.

Rising ADHD diagnoses have increased the number of people relying on the same limited pool of medication, which can empty out even well-stocked pharmacies faster than manufacturers can resupply them.

Medication Savings With ScriptSave® WellRx

Navigating a medication shortage is stressful enough without worrying about cost on top of it. If your prescriber has you on brand Vyvanse or generic lisdexamfetamine, ScriptSave® WellRx can help you compare prices at pharmacies near you before you fill. Some people save a little, some save a lot, since prices can vary significantly even between pharmacies located across the street from each other.

Our average savings is 75%, and some patients save up to 80%*. ScriptSave has been helping people save on prescriptions for 25 years, and our free savings card works whether you're filling brand or generic, with or without insurance.

*DISCOUNT ONLY – NOT INSURANCE. The program is administered by Medical Security Card Company, LLC.

Author Bio

Alyse Thompson, M.D., is a freelance medical writer with experience caring for patients in primary and urgent care settings. She also has a master's degree in basic medical science. She has managed acute and chronic diseases and participated in medical and pharmaceutical research.

References

https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=961

https://www.accessdata.fda.gov/scripts/drugshortages/

https://emergency.cdc.gov/han/2024/han00510.asp

https://www.cdc.gov/mmwr/volumes/73/wr/mm7340a1.htm

https://www.govinfo.gov/content/pkg/FR-2026-01-05/pdf/2025-24277.pdf

https://www.dea.gov/drug-information/drug-scheduling